Cargando…
Modeling colorectal cancer: A bio‐resource of 50 patient‐derived organoid lines
BACKGROUND AND AIM: Colorectal cancer (CRC) is the second leading cause of cancer death worldwide. To improve outcomes for these patients, we need to develop new treatment strategies. Personalized cancer medicine, where patients are treated based on the characteristics of their own tumor, has gained...
Autores principales: | Engel, Rebekah M, Jardé, Thierry, Oliva, Karen, Kerr, Genevieve, Chan, Wing Hei, Hlavca, Sara, Nickless, David, Archer, Stuart K, Yap, Raymond, Ranchod, Pravin, Bell, Stephen, Niap, Ann, Koulis, Christine, Chong, Ashley, Wilkins, Simon, Dale, Trevor C, Hollins, Andrew J, McMurrick, Paul J, Abud, Helen E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138743/ https://www.ncbi.nlm.nih.gov/pubmed/35244298 http://dx.doi.org/10.1111/jgh.15818 |
Ejemplares similares
-
Patient-Derived Colorectal Cancer Organoids Upregulate Revival Stem Cell Marker Genes Following Chemotherapeutic Treatment
por: Engel, Rebekah M., et al.
Publicado: (2020) -
Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer
por: Koulis, Christine, et al.
Publicado: (2020) -
ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer
por: Jardé, Thierry, et al.
Publicado: (2015) -
The Effect of Diabetes on the Perioperative Outcomes of Colorectal Cancer Surgery Patients
por: Yap, Raymond, et al.
Publicado: (2016) -
SRSF3 shapes the structure of miR‐17‐92 cluster RNA and promotes selective processing of miR‐17 and miR‐20a
por: Ratnadiwakara, Madara, et al.
Publicado: (2023)